Detecting neoplasm

US10590489B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10590489-B2
Application numberUS-201715724890-A
CountryUS
Kind codeB2
Filing dateOct 4, 2017
Priority dateFeb 15, 2008
Publication dateMar 17, 2020
Grant dateMar 17, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This document relates to methods and materials for detecting premalignant and malignant neoplasms. For example, methods and materials for determining whether or not a stool sample from a mammal contains nucleic acid markers or polypeptide markers of a neoplasm are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method, comprising: (a) extracting genomic DNA from a biological sample of a human individual suspected of having precancer or colorectal cancer, wherein the biological sample is a stool sample; (b) amplifying a portion of the extracted genomic DNA with primers specific for K-ras, and measuring a K-ras mutation score by performing a digital melt curve analysis or quantitative allele-specific PCR; and (c) treating a portion of the extracted genomic DNA with bisulfite; amplifying the bisulfite-treated genomic DNA with primers specific for BMP3; and measuring the methylation level of one or more CpG sites in BMP3 by methylation-specific PCR, quantitative methylation-specific PCR, methylation-sensitive DNA restriction enzyme analysis, quantitative bisulfite pyrosequencing, or bisulfite genomic sequencing PCR. 2. The method of claim 1 , wherein the primers specific for K-ras are selected from SEQ ID NOs: 2, 3, 4, 5, 6, 7 and 8.

Assignees

Inventors

Classifications

  • Alpha-amylase (3.2.1.1) · CPC title

  • Methylation markers · CPC title

  • Chemical aspects of mass spectrometric analysis of biological material · CPC title

  • involving peptidase or proteinase · CPC title

  • involving amylase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10590489B2 cover?
This document relates to methods and materials for detecting premalignant and malignant neoplasms. For example, methods and materials for determining whether or not a stool sample from a mammal contains nucleic acid markers or polypeptide markers of a neoplasm are provided.
Who is the assignee on this patent?
Mayo Found Medical Education & Res
What technology area does this patent fall under?
Primary CPC classification C12Q1/6886. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).